Lupin Ltd. To Launch Nearly 30 Products In U.S. Market This Financial Year
An employee holds Ramipril capsules for a photograph inside a coating unit at the Lupin Ltd. pharmaceutical plant in Salcette, Goa, India. (Photographer: Dhiraj Singh/Bloomberg)

Lupin Ltd. To Launch Nearly 30 Products In U.S. Market This Financial Year

Bookmark
With rapid approvals anticipated from U.S. health regulators, home-grown drug major Lupin Ltd. sees opportunity to launch around 30 generic products in the world's largest pharmaceuticals market th...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.